Distinct altered patterns of p27KIP1 gene expression in benign prostatic hyperplasia and prostatic carcinoma
- PMID: 9731735
- DOI: 10.1093/jnci/90.17.1284
Distinct altered patterns of p27KIP1 gene expression in benign prostatic hyperplasia and prostatic carcinoma
Abstract
Background: The p27KIP1 gene, whose protein product is a negative regulator of the cell cycle, is a potential tumor suppressor gene; however, no tumor-specific mutations of this gene have been found in humans. This study was undertaken to identify and to assess potential alterations of p27KIP1 gene expression in patients with benign prostatic hyperplasia (BPH) and patients with prostate cancer.
Methods: We analyzed 130 prostate carcinomas from primary and metastatic sites, as well as prostate samples from normal subjects and from patients with BPH. Immunohistochemistry and in situ hybridization were used to determine the levels of expression and the microanatomical localization of p27 protein and messenger RNA (mRNA), respectively. Immunoblotting and immunodepletion assays were performed on a subset of the prostate tumors. Associations between alterations in p27KIP1 expression and clinicopathologic variables were evaluated with a nonparametric test. The Kaplan-Meier method and the logrank test were used to compare disease-relapse-free survival. Prostate tissues of p27Kip1 null (i.e., knock-out) and wild-type mice were also evaluated.
Results: Normal human prostate tissue exhibited abundant amounts of p27 protein and high levels of p27KIP1 mRNA in both epithelial cells and stromal cells. However, p27 protein and p27KIP1 mRNA were almost undetectable in epithelial cells and stromal cells of BPH lesions. Furthermore, p27Kip1 null mice developed enlarged (hyperplastic) prostate glands. In contrast to BPH, prostate carcinomas were found to contain abundant p27KIP1 mRNA but either high or low to undetectable levels of p27 protein. Primary prostate carcinomas expressing lower levels of p27 protein appeared to be biologically more aggressive (two-sided P = .019 [Cox regression analysis]).
Conclusions/implications: On the basis of these results, we infer that loss of p27Kip1 expression in the human prostate may be causally linked to BPH and that BPH is not a precursor to prostate cancer.
Comment in
-
Re: Distinct altered patterns of p27KIP1 gene expression in benign prostatic hyperplasia and prostatic carcinoma.J Natl Cancer Inst. 1999 Jan 6;91(1):91. J Natl Cancer Inst. 1999. PMID: 9890179 No abstract available.
Similar articles
-
Prostate stem cell compartments: expression of the cell cycle inhibitor p27Kip1 in normal, hyperplastic, and neoplastic cells.Am J Pathol. 1998 Sep;153(3):911-9. doi: 10.1016/S0002-9440(10)65632-5. Am J Pathol. 1998. PMID: 9736039 Free PMC article.
-
Re: Distinct altered patterns of p27KIP1 gene expression in benign prostatic hyperplasia and prostatic carcinoma.J Natl Cancer Inst. 1999 Jan 6;91(1):91. J Natl Cancer Inst. 1999. PMID: 9890179 No abstract available.
-
Apoptosis incidence and protein expression of p53, TGF-beta receptor II, p27Kip1, and Smad4 in benign, premalignant, and malignant human prostate.Hum Pathol. 2004 Mar;35(3):290-7. doi: 10.1016/j.humpath.2003.11.001. Hum Pathol. 2004. PMID: 15017584
-
Stem cell features of benign and malignant prostate epithelial cells.J Urol. 1998 Dec;160(6 Pt 2):2381-92. doi: 10.1097/00005392-199812020-00004. J Urol. 1998. PMID: 9817389 Review.
-
New concepts in tissue specificity for prostate cancer and benign prostatic hyperplasia.Urology. 1999 Mar;53(3 Suppl 3a):29-39; discussion 39-42. doi: 10.1016/s0090-4295(98)00536-6. Urology. 1999. PMID: 10094098 Review.
Cited by
-
Interaction of Nkx3.1 and p27kip1 in prostate tumor initiation.Am J Pathol. 2004 May;164(5):1607-14. doi: 10.1016/S0002-9440(10)63719-4. Am J Pathol. 2004. PMID: 15111307 Free PMC article.
-
Stromally expressed c-Jun regulates proliferation of prostate epithelial cells.Am J Pathol. 2007 Oct;171(4):1189-98. doi: 10.2353/ajpath.2007.070285. Epub 2007 Aug 16. Am J Pathol. 2007. PMID: 17702894 Free PMC article.
-
The Role of Heat Shock Protein 70 Subfamily in the Hyperplastic Prostate: From Molecular Mechanisms to Therapeutic Opportunities.Cells. 2022 Jun 28;11(13):2052. doi: 10.3390/cells11132052. Cells. 2022. PMID: 35805135 Free PMC article. Review.
-
Pten dose dictates cancer progression in the prostate.PLoS Biol. 2003 Dec;1(3):E59. doi: 10.1371/journal.pbio.0000059. Epub 2003 Oct 27. PLoS Biol. 2003. PMID: 14691534 Free PMC article.
-
Mouse models of prostate cancer: picking the best model for the question.Cancer Metastasis Rev. 2014 Sep;33(2-3):377-97. doi: 10.1007/s10555-013-9487-8. Cancer Metastasis Rev. 2014. PMID: 24452759 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical